Krystal Biotech, Inc.

NASDAQ:KRYS

155.81 (USD) • At close January 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q2
Revenue 83.84170.28445.2542.1438.55600000000000000000.5420.5831.0270.2170.1730.127000000
Cost of Revenue 6.6847.9952.4194.3780.2231.21.11.0890.9750.9761.0150.7840.7830.6650.536000000000000000000
Gross Profit 77.15762.28942.83137.7658.333-1.2-1.1-1.089-0.975-0.976-1.015-0.784-0.783-0.665-0.5360000000.5420.5831.0270.2170.1730.127000000
Gross Profit Ratio 0.920.8860.9470.8960.9740000000000000000111111000000
Reseach & Development Expenses 13.51115.58310.95711.3710.62912.14412.28810.74111.51610.899.3149.0096.086.5946.2015.6725.13.6393.5254.3493.8854.2163.1672.8021.9141.5251.521.0881.3550.4460.3190.4020.241
General & Administrative Expenses 00073.63623.69725.90424.03524.0319.93517.86315.90812.8679.5729.7998.1524.7484.583.3152.4211.8051.4571.6741.5271.4171.0580.9240.7570.410.7380.2690.1460.2180.081
Selling & Marketing Expenses 000-50.37900000000000000000000000000000
SG&A 28.71325.6426.05823.25723.69725.90424.03524.0319.93517.86315.90812.8679.5729.7998.1524.7484.583.3152.4211.8051.4571.6741.5271.4171.0580.9240.7570.410.7380.2690.1460.2180.081
Other Expenses 12.518.50914.9192.8710.223012.52500250000000000000000000000
Operating Expenses 54.72441.22337.01534.62734.54938.04836.32334.77131.45128.75325.22221.87615.65216.39314.35310.429.686.9545.9466.1545.3425.894.6944.2192.9722.4492.2771.4982.0930.7150.4650.620.322
Operating Income 22.43321.066-6.6843.138-25.993-38.048-48.823-34.771-31.451-28.753-50.222-21.876-15.652-16.393-14.353-10.42-9.68-6.954-5.946-6.154-5.342-5.89-4.694-4.219-2.972-2.449-2.277-1.498-2.093-0.715-0.465-0.62-0.322
Operating Income Ratio 0.2680.3-0.1480.074-3.0380000000000000000-10.867-8.051-4.108-13.696-14.156-17.929000000
Total Other Income Expenses Net 7.336-5.021-4.8847.519106.744.8383.5262.7191.6010.6450.2570.070.0630.03-1.4590.0370.070.1210.6050.7971.070.5420.5830.5110.2170.1730.1270.105-3.18-0.044-0.029-0.0070
Income Before Tax 29.76916.0450.93210.65780.747-33.21-45.297-32.052-29.85-28.108-49.965-21.806-15.589-16.363-15.812-10.383-9.61-6.833-5.341-5.357-4.272-5.348-4.111-3.708-2.755-2.276-2.15-1.393-5.273-0.759-0.494-0.627-0.322
Income Before Tax Ratio 0.3550.2280.0210.2539.4370000000000000000-9.867-7.051-3.611-12.696-13.156-16.929000000
Income Tax Expense 2.5890.4774.8841.965-0.8260.99625.652.5032.490.64525.2570.0710.0630.0310.033000000000000000000
Net Income 27.1815.5680.9328.69280.747-33.21-45.297-32.052-29.85-28.108-49.965-21.806-15.589-16.363-15.812-10.383-9.61-6.833-5.341-5.357-4.272-5.348-4.111-3.708-2.755-2.276-2.15-1.393-5.273-0.759-0.494-0.627-0.322
Net Income Ratio 0.3240.2220.0210.2069.4370000000000000000-9.867-7.051-3.611-12.696-13.156-16.929000000
EPS 0.950.540.030.312.88-1.25-1.76-1.25-1.17-1.1-1.99-0.95-0.7-0.74-0.74-0.53-0.49-0.37-0.31-0.31-0.25-0.37-0.29-0.27-0.26-0.22-0.21-0.14-1.26-0.087-0.12-0.15-0.075
EPS Diluted 0.910.530.030.32.79-1.25-1.76-1.25-1.17-1.1-1.99-0.94-0.7-0.74-0.74-0.53-0.49-0.37-0.31-0.31-0.25-0.37-0.29-0.27-0.26-0.22-0.21-0.14-1.26-0.087-0.12-0.15-0.075
EBITDA 31.25718.0312.54112.164-25.993-38.048-35.012-30.963-30.476-27.777-24.207-21.022-14.806-15.698-14.353-9.893-9.211-6.439-4.98-5.904-5.342-5.89-4.694-4.298-2.972-2.449-2.277-1.508-2.088-0.712-0.464-0.619-0.322
EBITDA Ratio 0.3730.3280.440.11-3.0380000000000000000-10.544-7.825-4.049-13.521-14.017-17.787000000